Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase...

Area of Science:

• Neuroscience
• Neurobiology
• Pharmacology

Background:

• The nucleus basalis magnocellularis (NBM) plays a crucial role in cognitive functions.
• Cholinergic neurons in the NBM are vulnerable to neurotoxic damage.
• Nerve growth factor (NGF) and monosialoganglioside GM1 are potential neuroprotective agents.

Purpose of the Study:

• To investigate the neuroprotective effects of NGF and GM1 on cholinergic neurons in an adult male rat model.
• To determine if combined administration of NGF and GM1 enhances neuroprotection compared to individual treatments.
• To assess the impact of these treatments on high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity.

Main Methods:

• Adult male rats received unilateral ibotenic acid lesions of the NBM.
• Rats were treated with NGF, GM1, or both, starting immediately after lesioning.
• HACU rate and ChAT activity were measured in cortical tissue 4 and 21 days post-surgery.

Main Results:

• Ibotenic acid lesions significantly decreased HACU rate and ChAT activity in ipsilateral cortices.
• Both NGF and GM1 treatment alone reduced the extent of these decreases.
• Concomitant administration of NGF and GM1 prevented the decrease in HACU and ChAT activity, with a slight increase in the contralateral hemisphere.

Conclusions:

• NGF and GM1 exhibit neuroprotective effects on cholinergic neurons of the NBM.
• Combined administration of NGF and GM1 potentiates neuroprotection, suggesting a synergistic effect.
• These findings indicate potential therapeutic strategies for conditions involving cholinergic neurodegeneration.